Charité Center for Internal Medicine and Dermatology, Division for General Internal and Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Medicine, CURE Digestive Diseases Research Center and Center for Neurobiology of Stress, Digestive Diseases Division UCLA, and VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Horm Metab Res. 2013 Dec;45(13):975-9. doi: 10.1055/s-0033-1351324. Epub 2013 Sep 18.
Hunger and satiety are regulated in a complex fashion by a few food intake stimulatory (orexigenic) and a multitude of inhibitory (anorexigenic) factors produced in the periphery (mainly in the gastrointestinal tract) or directly in the brain. Within the brain, the hypothalamus plays a pivotal role as a production site of food intake regulatory factors. Importantly, this site integrates peripheral and central signaling factors to orchestrate food intake and in the long term body weight. Our knowledge on these regulatory pathways is not static but rather rapidly changing as new factors as well as up- and downstream signaling pathways of already known transmitters are uncovered. Hypothalamic nucleobindin2 (NUCB2), the precursor of nesfatin-1, was first described in 2006 and nesfatin-1 found to be a novel anorexigenic modulator of food intake and body weight. The initial report stimulated several groups to investigate the biological actions of nesfatin-1 and subsequent studies delineated the underlying brain mechanisms involved in its food reducing effect. Of interest was the demonstration that NUCB2 also exerts its anorexigenic action in the paraventricular nucleus of the hypothalamus and is regulated at this site by changes in metabolic status with a diurnal rhythm inversely related to that of feeding in rats. The present review describes the current state-of-knowledge on central nesfatin-1's effects on food intake and body weight and highlights important missing links regarding cellular signaling mechanisms involved in nesfatin-1's action.
饥饿和饱腹感通过少数食物摄入刺激物(食欲刺激物)和大量在周围(主要在胃肠道)或直接在大脑中产生的抑制性(厌食性)因素以复杂的方式调节。在大脑中,下丘脑作为食物摄入调节因子的产生部位起着关键作用。重要的是,该部位整合了外周和中枢信号因子,以协调食物摄入和长期体重。我们对这些调节途径的了解并非静态的,而是随着新的因素以及已经知道的递质的上下游信号途径的发现而迅速变化。下丘脑核结合蛋白 2(NUCB2)是 nesfatin-1 的前体,于 2006 年首次描述,nesfatin-1 被发现是一种新型的食欲抑制剂,可调节食物摄入和体重。最初的报告促使多个小组研究 nesfatin-1 的生物学作用,随后的研究描绘了其减少食物摄入作用所涉及的潜在大脑机制。有趣的是,证明 NUCB2 也在下丘脑室旁核发挥其厌食作用,并且其在该部位的调节受代谢状态变化的影响,其昼夜节律与大鼠的摄食呈相反关系。本综述描述了中枢 nesfatin-1 对食物摄入和体重的影响的最新知识,并强调了涉及 nesfatin-1 作用的细胞信号机制的重要缺失环节。